| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
MDVL Overview
MedAvail Holdings, Inc. operates as a technology enabled pharmacy company that embeds automated pharmacy services directly into clinics and other points of care through its proprietary technology.
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.58 |
| 52 Week High | US$2.52 |
| 52 Week Low | US$20.79 |
| Beta | 0 |
| 1 Month Change | -19.12% |
| 3 Month Change | -72.23% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -71.33% |
Recent News & Updates
Some Analysts Just Cut Their MedAvail Holdings, Inc (NASDAQ:MDVL) Estimates
The latest analyst coverage could presage a bad day for MedAvail Holdings, Inc ( NASDAQ:MDVL ), with the analysts...
Calculating The Intrinsic Value Of MedAvail Holdings, Inc (NASDAQ:MDVL)
Does the May share price for MedAvail Holdings, Inc ( NASDAQ:MDVL ) reflect what it's really worth? Today, we will...
Shareholder Returns
| MDVL | US Consumer Retailing | US Market | |
|---|---|---|---|
| 7D | -7.9% | 4.6% | 1.7% |
| 1Y | n/a | 13.9% | 30.3% |
Return vs Industry: Insufficient data to determine how MDVL performed against the US Consumer Retailing industry.
Return vs Market: Insufficient data to determine how MDVL performed against the US Market.
Price Volatility
| MDVL volatility | |
|---|---|
| MDVL Beta | 0 |
| Industry Beta | 0.62 |
| Market Beta | 1 |
Stable Share Price: MDVL is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 18% a week.
Volatility Over Time: MDVL's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 224 | Ed Kilroy | https://www.medavail.com |
MedAvail Holdings, Inc. operates as a technology enabled pharmacy company that embeds automated pharmacy services directly into clinics and other points of care through its proprietary technology. The company provides turnkey services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations. It also operates SpotRx, a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery.
MedAvail Holdings Fundamentals Summary
| MDVL fundamental statistics | |
|---|---|
| Market Cap | US$84.49m |
| Earnings (TTM) | -US$34.50m |
| Revenue (TTM) | US$19.30m |
4.4x
P/S Ratio-2.4x
P/E RatioIs MDVL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDVL income statement (TTM) | |
|---|---|
| Revenue | US$19.30m |
| Cost of Revenue | US$14.07m |
| Gross Profit | US$5.23m |
| Expenses | US$39.73m |
| Earnings | -US$34.50m |
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.05 |
| Gross Margin | 27.10% |
| Net Profit Margin | -178.74% |
| Debt/Equity Ratio | 24.7% |
How did MDVL perform over the long term?
See historical performance and comparisonValuation
Is MedAvail Holdings undervalued compared to its fair value and its price relative to the market?
2.01x
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate MDVL's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate MDVL's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: MDVL is unprofitable, so we can't compare its PE Ratio to the US Consumer Retailing industry average.
PE vs Market: MDVL is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate MDVL's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: MDVL is good value based on its PB Ratio (2x) compared to the US Consumer Retailing industry average (2.3x).
Future Growth
How is MedAvail Holdings forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
8.4%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MDVL is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: MDVL is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: MDVL is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: MDVL's revenue (50.2% per year) is forecast to grow faster than the US market (9.9% per year).
High Growth Revenue: MDVL's revenue (50.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MDVL's Return on Equity is forecast to be high in 3 years time
Past Performance
How has MedAvail Holdings performed over the past 5 years?
-44.9%
Last years earnings growth
Earnings and Revenue History
Quality Earnings: MDVL is currently unprofitable.
Growing Profit Margin: MDVL is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if MDVL's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare MDVL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MDVL is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (25%).
Return on Equity
High ROE: MDVL has a negative Return on Equity (-81.95%), as it is currently unprofitable.
Financial Health
How is MedAvail Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: MDVL's short term assets ($54.1M) exceed its short term liabilities ($8.9M).
Long Term Liabilities: MDVL's short term assets ($54.1M) exceed its long term liabilities ($10.2M).
Debt to Equity History and Analysis
Debt Level: MDVL's debt to equity ratio (24.7%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if MDVL's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MDVL has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: MDVL has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 38.4% each year.
Dividend
What is MedAvail Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MDVL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MDVL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MDVL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MDVL's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MDVL's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
0.8yrs
Average management tenure
CEO
Ed Kilroy (61 yo)
0.92
Tenure
US$440,771
Compensation
Mr. Edwin J. Kilroy, also known as Ed, is President, Chief Executive Officer and Director of MedAvail Holdings, Inc since November 16, 2020. He has served as Private MedAvail President and Chief Executive...
CEO Compensation Analysis
Compensation vs Market: Ed's total compensation ($USD440.77K) is about average for companies of similar size in the US market ($USD545.51K).
Compensation vs Earnings: Ed's compensation has increased whilst the company is unprofitable.
Leadership Team
Experienced Management: MDVL's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
Experienced Board: MDVL's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: MDVL only recently listed within the past 12 months.
Top Shareholders
Company Information
MedAvail Holdings, Inc's employee growth, exchange listings and data sources
Key Information
- Name: MedAvail Holdings, Inc
- Ticker: MDVL
- Exchange: NasdaqCM
- Founded: NaN
- Industry: Drug Retail
- Sector: Consumer Retailing
- Market Cap: US$84.486m
- Shares outstanding: 32.75m
- Website: https://www.medavail.com
Number of Employees
Location
- MedAvail Holdings, Inc
- 6665 Millcreek Drive
- Unit 1
- Mississauga
- Ontario
- L5N 5M4
- Canada
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/10/22 23:08 |
| End of Day Share Price | 2021/10/22 00:00 |
| Earnings | 2021/06/30 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.